Ethan Davidoff’s Post

I cannot even put into words, the power, courage, and perseverance that Peter Mang and Katie Mang continue to model in a world where #cancer hits close to home. If you wanna learn more about Pete and Katie‘s journey, or the impacts of glioblastoma and how you can help, follow Go With The Good Foundation connect with Katie Mang and Julie Wilson. #glioblastoma #kindnessmatters #helpingothers #womenwholead

❌Myth: Trial participants find giving feedback to be a burden ✅Fact: They want to share their feedback, and have no way to do so Only 3% of trial participants are asked for their feedback on their trial, yet when we asked a patient advocacy group for their input, every single participant asked for longer surveys, more often. This is why Cancer Research UK (CRUK) are seeing more than 1 survey response per patient in one of their studies. This is a huge opportunity for the industry as feedback helps you to improve your trial design, and is a major part of patient engagement. Thanks to Dave Marshall for sharing his learnings. Read more of our learnings here: https://lnkd.in/e6ke-FeP

🌟 Happy #MerlinMonday, Followers! 🌟 How's everyone doing today? 😊 Let's kick off the week with some positivity! Today, our spotlight shines on one of our specialized services: Oncology-Specific Support! 🩺💪 In the dynamic world of oncology clinical trials, specialized support is essential for navigating complex protocols, stringent regulations, and unique patient needs. At Merlin SCC, we offer tailored solutions to meet the unique challenges of oncology research. From protocol design to patient recruitment and safety monitoring, our team provides comprehensive support throughout the trial lifecycle. Trust Merlin SCC to be your partner in advancing oncology research and improving patient outcomes. Choose expertise, choose reliability, choose Merlin SCC for your Oncology-Specific Support needs! #MerlinMonday #OncologySupport #ClinicalTrials #ChooseMerlinSCC #HealthcareInnovation #SupplyChainManagement 🌐

We launched the Health Equity Innovation Fund in 2019 to support organizations with transformative ideas to advance the healthcare system and eliminate deep-rooted inequities. Since then, 77% of Innovation Fund grantees have reported increased commitment to health equity work at their institutions. Swipe to see how grantees Touch, The Black Breast Cancer Alliance, Equify Health, and Henry Ford Health have used their funding to shift power to patients and unlock innovation in care delivery, and learn more about the impact of the Innovation Fund here: https://lnkd.in/dT_tvBZ4

🌟 Don't miss our upcoming presentation at #ACE2024: Current State Overview on Patient Assistance Efficiencies for Cancer Centers. Join us to explore how addressing financial and health-related social needs can advance health equity in cancer care. Discover the latest insights from leading cancer centers and understand the impact of patient financial security on cancer outcomes. #HealthEquity #PatientAssistance https://hubs.la/Q02cGsQx0

🌟 Don't miss our upcoming presentation at #ACE2024: Current State Overview on Patient Assistance Efficiencies for Cancer Centers. Join us to explore how addressing financial and health-related social needs can advance health equity in cancer care. Discover the latest insights from leading cancer centers and understand the impact of patient financial security on cancer outcomes. #HealthEquity #PatientAssistance https://hubs.ly/Q02f2vcw0

🚀 Exciting news! Next week, I’ll be attending the 2024 Association for Value-Based Cancer Care Conference in New York, and couldn’t be more thrilled to share the stage with some of the brightest minds in oncology and technology. 💡🎤 We’ll be diving deep into "The Practice Analytics Imperative: Better Measurement for Better Management." 🔍 In today’s data-driven world, oncology practices are sitting on vast amounts of information, but unlocking the real value requires breaking down silos and improving interoperability. I'll be sharing my thoughts on: - The most persistent barriers to interoperability 🧩 - How AI and technology are shaping the future of practice analytics ⚙️ - Solutions to help practices leverage their data, even when they lack in-house expertise 💼 It’s going to be an insightful discussion, and I can’t wait to hear perspectives from industry leaders and share Navista's vision on how we can help practices harness the full potential of their data. If you’re attending, let’s connect! Looking forward to learning, sharing, and driving innovation in the oncology space. #AVBCC2024 #OncologyAnalytics #ValueBasedCare #Interoperability #HealthcareInnovation #DataDrivenDecisions #Navista #OncologyLeadership

Back by popular demand! These expert panelists will bring the insided scoop on the latest legislative updates and how they will shape the future of oncology care. This must-attend session is sure to inform and spark conversations!  Nicolas Ferreyros, Jonathan Levitt, Megan Mullaney, Judith Alberto,

Sharing more photos from our press event on September 16th at the National Press Club, which highlighted progress achieved by the I-SPY 2.2 clinical trial. This new generation of patient-centered trials is poised to not only improve the health outcomes of early stage high-risk breast cancer patients, but to also accelerate the development of targeted treatments and therapies for other cancers and complex diseases. Thank you to our wonderful panel and speakers, who are pictured, and include: Dr. Anna D. Barker, PhD, Chief Strategy Officer Lawrence J. Ellison Institute for Transformative Medicine; janet woodcock, MD, former FDA Principal Deputy Commissioner; Dr. Laura Esserman, MD, Principal Investigator of ISPY 2.2; Dr. Angela DeMichele MD, MSCE, FASCO, ISPY Investigator; Laura van 't Veer, PhD; Jan Tomlinson, patient advocate; and Mr. Clifton Leaf, former Editor in Chief, Fortune Magazine. You can learn more about I-SPY 2.2 at https://lnkd.in/g5nB_NtR. . . . #HealthcareForAll #InnovateHealthcare #PersonalizedMedicine #PatientCare #HealthEquity #HealthcareInnovation #BridgingResearchAndCare #IntegrityInHealthcare #CollaborativeCare #TransparencyInHealth #FutureOfHealthcare #ScienceAndCare #HealthcareLeadership #HealthForAll #MedicalInnovation #nonprofit #clinicaltrials #datacollection #healthdata #researchdata #diseaseresearch #findacure #nonprofit 

As the end-of-year approaches and resolutions for 2024 are made, it is also a time to sustain and become more prepared to proactively integrate financial health into the overall cancer care plan, and help patients access affordable, high-quality care for improved quality of life. ACCC’s Financial Advocacy Network released its new consensus-based Oncology Financial Advocacy Services Guidelines, a framework for oncology financial services that helps programs prevent, detect and mitigate financial hardship for their patients during cancer care. Access the Oncology Financial Advocacy Services Guidelines for FREE: https://bit.ly/40BLII2